India Life Sciences Fund II invests in MedTech Cos

17 February 2015 | News | By BioSpectrum Bureau

The fund has invested in Comprehensive Prosthetics and Orthotics (CPO) and Relisys Medical Devices

Reportedly, India Life Sciences Fund II has invested Rs 92 crore (approx $15 million) in Comprehensive Prosthetics and Orthotics (CPO) and Relisys Medical Devices.

New Delhi-based Comprehensive Prosthetics and Orthotics (CPO) makes artificial limbs, while Hyderabad-based Relisys Medical Devices is involved in development, manufacturing and commercialization of medical devices to treat life-threatening diseases including cardiovascular, peripheral vascular, neurovascular (stroke), and structural heart disease.

The fund has invested Rs 60 crore in CPO and the rest Rs 32 crore in Relisys.

It has raised Rs 865 crore last year to invest in mid-market companies in healthcare services, pharmaceuticals and medical technology.